Drug Profile
Gluconoct
Alternative Names: GluconoctLatest Information Update: 03 Apr 2007
Price :
$50
*
At a glance
- Originator Metcon Medicin
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Hypoglycaemia
Most Recent Events
- 03 Apr 2007 No development reported - Phase-II for Hypoglycaemia prevention in Sweden (unspecified route)
- 15 Sep 2003 Gluconoct is available for licensing (http://www.metconmedicin.se)
- 15 Sep 2003 Phase-II clinical trials in Hypoglycaemia prevention in Sweden (unspecified route)